Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2014
11/13/2014US20140335170 Reduced Mass Metformin Formulations
11/13/2014US20140335165 Sustained-release nucleic acid matrix compositions
11/13/2014US20140335161 Compositions and Methods for the Diagnosis and Therapy of BCL2-Associated Cancers
11/13/2014US20140335154 Methods and formulations to achieve tumor targeted double stranded rna mediated cell death
11/13/2014US20140335152 Methods and compositions for enhancing the uptake of therapeutic agents by target cells
11/13/2014US20140335151 Patch containing non-steroidal anti-inflammatory drug
11/13/2014US20140335150 Therapeutic patch
11/13/2014US20140335145 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them
11/13/2014US20140335140 Natural volatile plant oils to repel arthropods
11/13/2014US20140335133 Low-oil pharmaceutical emulsion compositions comprising progestogen
11/13/2014US20140335132 Binding drugs with nanocrystalline cellulose (ncc)
11/13/2014US20140335131 Probiotic prevention and treatment of colon cancer
11/13/2014US20140335130 Amino acid supplementation for a healthy microbiota ecosystem
11/13/2014US20140335122 Compound, extract isolated from antrodia camphorate, and method using the same
11/13/2014US20140335113 Factor h for transplantation
11/13/2014US20140335109 Combination of inotuzumab ozogamicin and torisel for the treatment of cancer
11/13/2014US20140335106 Methods and pharmaceutical compositions for treating cancer
11/13/2014US20140335105 Methods of generating hyper inos expressing cells and uses thereof
11/13/2014US20140335100 Therapy-enhancing glucan
11/13/2014US20140335091 Anti-glucagon receptor antibodies and methods of use thereof
11/13/2014US20140335083 Methods of treatment and prevention of eye diseases
11/13/2014US20140335081 Treatment For Rheumatoid Arthritis
11/13/2014US20140335080 Ester derivatives of androgen receptor modulators and methods for their use
11/13/2014US20140335079 Solenopsin and derivatives, therapeutic compositions, and methods related thereto
11/13/2014US20140335077 Compositions and Methods for the Treatment of Cancer Using IGF-IR Antagonists and MAPK/ERK Inhibitors
11/13/2014US20140335074 Methods for improving medical therapies
11/13/2014US20140335073 Nutrition for prevention of infections
11/13/2014US20140335065 Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
11/13/2014US20140335061 Supplemented oil compositions and methods for improved health
11/13/2014US20140335056 Sustained releasing pharmaceutical composition
11/13/2014US20140335052 Combination therapy for treating hcv infection in an hcv-hiv coinfected patient population
11/13/2014US20140335050 Methods, compositions, and kits for the treatment of cancer
11/13/2014US20140335048 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, Salts Thereof and Methods of Using the Same in Combination Therapy
11/13/2014US20140335047 Drug delivery product and methods
11/13/2014US20140335036 Hair care conditioning composition comprising histidine
11/13/2014US20140335029 Use of cyclohexanol derivatives as antimicrobial active compounds
11/13/2014US20140335027 Heatiness and salivary secretory immunoglobulin
11/13/2014US20140335025 Targeting corroles for tumor toxicity and mri
11/13/2014US20140335018 Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging
11/13/2014US20140332438 Water-soluble meloxicam granules
11/11/2014US8884061 Compositions and methods of use of electron transport system inhibitors
11/11/2014US8884034 TOFA analogs useful in treating dermatological disorders or conditions
11/11/2014US8884033 Process for preparing aminobenzoylbenzofuran derivatives
11/11/2014US8884032 Trioxane monomers and dimers
11/11/2014US8884030 Inhibitors of Flaviviridae viruses
11/11/2014US8884026 Process for preparing rufinamide intermediate
11/11/2014US8884023 Pyrano [3,2-D][1,3]thiazole as glycosidase inhibitors
11/11/2014US8884019 Benzimidazole compound crystal
11/11/2014US8884013 Polymorphs of Dasatinib, preparation methods and pharmaceutical compositions thereof
11/11/2014US8883987 Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides
11/11/2014US8883966 RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
11/11/2014US8883863 Safety of psuedoephedrine drug products
11/11/2014US8883861 Iminic monomers and polymers thereof
11/11/2014US8883859 Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-) -carvone, geraniol and a further essential oil component
11/11/2014US8883858 Small molecule xanthine oxidase inhibitors and methods of use
11/11/2014US8883857 Small molecule xanthine oxidase inhibitors and methods of use
11/11/2014US8883856 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
11/11/2014US8883855 Role of N-2-hydroxy-ethyl-piperazine-N′-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury
11/11/2014US8883853 N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
11/11/2014US8883852 Radioprotective agents
11/11/2014US8883851 Process for the preparation of vorinostat
11/11/2014US8883850 Naphthalene carboxamide M1 receptor positive allosteric modulators
11/11/2014US8883849 Treatment of sleep disturbances
11/11/2014US8883848 Enhanced microbial peracid compositions and methods of use at reduced temperatures in aseptic cleaning
11/11/2014US8883847 Compositions and methods of treatment using modulators of motoneuron diseases
11/11/2014US8883846 Synthesis of bicyclic compounds and method for their use as therapeutic agents
11/11/2014US8883845 Method for treating bronchial diseases
11/11/2014US8883844 Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
11/11/2014US8883843 Substituted isoindoline-1,3-dione derivatives
11/11/2014US8883842 Use of HDAC inhibitors for the treatment of myeloma
11/11/2014US8883841 Oncogenic ras-specific cytotoxic compound and methods of use thereof
11/11/2014US8883840 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
11/11/2014US8883839 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
11/11/2014US8883838 Pharmaceutical cream compositions and methods of use
11/11/2014US8883837 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
11/11/2014US8883834 Methods and compositions for locally increasing body fat
11/11/2014US8883833 Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
11/11/2014US8883832 Compounds, compositions, and methods for preventing metastasis of cancer cells
11/11/2014US8883831 Compositions and methods for minimizing or reversing agonist-induced desensitization
11/11/2014US8883830 Topical therapy for the treatment of migraines, muscle sprains, muscle spasms, spasticity and related conditions
11/11/2014US8883829 2-phenyl-1,2,3-benzotriazoles for UV radiation absorbance
11/11/2014US8883827 Azole derivatives as WTN pathway inhibitors
11/11/2014US8883826 Alkynyl derivatives as modulators of metabotropic glutamate receptors
11/11/2014US8883825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
11/11/2014US8883824 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
11/11/2014US8883823 Crystalline forms of a prolyl hydroxylase inhibitor
11/11/2014US8883822 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
11/11/2014US8883821 Substituted pyrazolo[3,4-b]pyridines as medicaments
11/11/2014US8883820 Triazole derivatives as kinase inhibitors
11/11/2014US8883819 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
11/11/2014US8883818 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/11/2014US8883817 Combination analgesic employing opioid and neutral antagonist
11/11/2014US8883816 Fused and spirocycle compounds and the use thereof
11/11/2014US8883815 Treatment for cerebral palsy impaired speech in children
11/11/2014US8883814 Compositions and methods for enhancing brain function
11/11/2014US8883813 Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes
11/11/2014US8883812 Piperidinyl pyrimidine amides as Kv7 potassium channel openers
11/11/2014US8883810 Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
11/11/2014US8883809 Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof
11/11/2014US8883808 Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapy
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 7860